Target intelligence / Profile preview

cAMP-regulated phosphoprotein 21 (ARPP21)

Target
ARPP21
Molecular classification
RNA-binding protein (RBP), Intracellular signaling molecule (as a phosphoprotein), Other (not classified as receptor/enzyme/transporter/transcription factor)
01

Overview

cAMP-regulated phosphoprotein 21 (ARPP21) is a highly conserved RNA-binding phosphoprotein enriched in certain brain regions, notably the striatum and cortex. ARPP21 recognizes uridine-rich sequences in the 3′ untranslated regions of target mRNAs, promoting their translation by interacting with components of the translation initiation complex (particularly eIF4F). This action counterbalances repression by microRNA miR-128, which is encoded within the ARPP21 host gene. ARPP21 plays pivotal roles in neuronal excitability, dendritic branching, and post-transcriptional control of gene expression in neural development. In the thymus, ARPP21 directly binds and promotes Rag1 mRNA translation, enhancing T cell receptor (TCR) repertoire diversity. The protein is subject to regulation by phosphorylation and ubiquitination in response to calcium signaling. Although implicated as a candidate gene for intellectual disability in CNVs and as part of a chemoresistance regulatory network in cancer, ARPP21 is not currently an established druggable target nor used in routine clinical biomarker assays.

Other names
ARPP-21R3HDM3RCSTARPPThymocyte cAMP-regulated phosphoproteinR3H domain containing 3
02

Mechanism of action

null

03

Biological functions

Post-transcriptional regulation of gene expression (especially in neural cells)Positive regulation of protein synthesis by interacting with the translation initiation complex eIF4FAntagonism of miR-128-mediated translational repressionRegulation of neuronal excitability and dendritic morphology/dendritogenesisPromotion of Rag1 mRNA expression in thymocytes; regulation of TCR repertoire diversityCandidate role in brain development and intellectual disability
04

Disease associations

Neurodevelopmental disorders (candidate gene for intellectual disability)Chemoresistance in non-small cell lung cancer (regulatory linkage with mutant p53)Possible, but not established, role in neurodegenerative diseases/ALSNo strong links to classic inflammation, cardiovascular, or infection roles

Beyond the preview

Go deeper on cAMP-regulated phosphoprotein 21 (ARPP21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cAMP-regulated phosphoprotein 21 (ARPP21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call